program for the development of genetic technologies, it demonstrates very bright results, and alexandrevich makarovs - coordinates the development of genetic technologies in medicine within the framework of this... a unique unique development made jointly with the biocad company, and i must immediately praise this company, we are very lucky with our industrial partner, because this highly competent company is very interested in real implementation, as quickly as possible, of what can be introduced, that is, it actually brings it to the market, as is now being done as part of the creation of the world’s first monoconal antibodies against the immune disease ankylosing spondylitis, this disease is generally terrible, the body goes crazy and begins to destroy its own cells, the person is crooked, it can’t affect the joints, yes , the joints are affected there, the spine becomes inflexible, there is pain in the joints, it is difficult to move, the musculoskeletal system suffers greatly, that is, the disease is terrible, a person can practically live with such a disease, of course. but in a very serious